Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 17 studies | 34% ± 16% | |
| pericyte | 11 studies | 21% ± 6% | |
| fibroblast | 9 studies | 23% ± 7% | |
| epithelial cell | 7 studies | 34% ± 16% | |
| endothelial cell | 6 studies | 28% ± 9% | |
| B cell | 5 studies | 16% ± 1% | |
| smooth muscle cell | 5 studies | 23% ± 7% | |
| abnormal cell | 4 studies | 20% ± 2% | |
| goblet cell | 4 studies | 18% ± 4% | |
| classical monocyte | 3 studies | 25% ± 7% | |
| non-classical monocyte | 3 studies | 29% ± 6% | |
| glomerular endothelial cell | 3 studies | 17% ± 1% | |
| connective tissue cell | 3 studies | 26% ± 2% | |
| capillary endothelial cell | 3 studies | 17% ± 3% | |
| endothelial cell of vascular tree | 3 studies | 18% ± 1% | |
| enteroendocrine cell | 3 studies | 25% ± 12% | |
| basal cell | 3 studies | 29% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 8270.71 | 258 / 258 | 100% | 50.90 | 230 / 230 |
| esophagus | 100% | 6584.21 | 1445 / 1445 | 100% | 20.73 | 183 / 183 |
| liver | 100% | 5485.40 | 226 / 226 | 100% | 43.69 | 406 / 406 |
| ovary | 100% | 9632.03 | 180 / 180 | 100% | 35.37 | 430 / 430 |
| pancreas | 100% | 8252.27 | 328 / 328 | 100% | 42.90 | 178 / 178 |
| thymus | 100% | 9563.11 | 653 / 653 | 100% | 47.29 | 605 / 605 |
| brain | 100% | 7405.11 | 2640 / 2642 | 100% | 53.07 | 705 / 705 |
| prostate | 100% | 8294.81 | 245 / 245 | 100% | 56.81 | 501 / 502 |
| uterus | 100% | 8435.81 | 170 / 170 | 100% | 40.77 | 458 / 459 |
| kidney | 100% | 8321.22 | 89 / 89 | 100% | 61.16 | 899 / 901 |
| intestine | 100% | 6677.43 | 966 / 966 | 100% | 36.85 | 525 / 527 |
| skin | 100% | 4941.83 | 1808 / 1809 | 100% | 42.14 | 470 / 472 |
| stomach | 100% | 6029.23 | 359 / 359 | 99% | 29.70 | 284 / 286 |
| lung | 100% | 6974.10 | 578 / 578 | 99% | 30.07 | 1144 / 1155 |
| breast | 100% | 6552.46 | 459 / 459 | 99% | 28.94 | 1107 / 1118 |
| bladder | 100% | 6163.67 | 21 / 21 | 99% | 38.03 | 498 / 504 |
| adipose | 100% | 6200.00 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 54.32 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 29.24 | 29 / 29 |
| muscle | 100% | 5226.74 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 7227.29 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 31.43 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 18.55 | 1 / 1 |
| heart | 100% | 7453.33 | 860 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 5684.61 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 3748.47 | 908 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1904691 | Biological process | negative regulation of type B pancreatic cell proliferation |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0034451 | Cellular component | centriolar satellite |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005634 | Cellular component | nucleus |
| GO_1990841 | Molecular function | promoter-specific chromatin binding |
| Gene name | WDR13 |
| Protein name | WD repeat domain 13 WDR13 WDR13 protein WD repeat-containing protein 13 |
| Synonyms | |
| Description | |
| Accessions | ENST00000376729.10 [Q9H1Z4-1] ENST00000470124.1 ENST00000486125.5 Q6NXG4 ENST00000498631.5 A0A087WWV5 Q06DW9 A0A087X091 Q9H1Z4 ENST00000218056.9 [Q9H1Z4-1] ENST00000482760.3 A0A087X2H9 |